IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,513,500 | +1.8% | 150,000 | 0.0% | 0.05% | +33.3% |
| Q3 2022 | $1,487,000 | +1.0% | 150,000 | 0.0% | 0.04% | +5.9% |
| Q2 2022 | $1,472,000 | 0.0% | 150,000 | 0.0% | 0.03% | +3.0% |
| Q1 2022 | $1,472,000 | +1.2% | 150,000 | 0.0% | 0.03% | -13.2% |
| Q4 2021 | $1,455,000 | +0.1% | 150,000 | 0.0% | 0.04% | -9.5% |
| Q3 2021 | $1,454,000 | +0.2% | 150,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $1,451,000 | – | 150,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |